{"disease":{"id":"brca-or-hrr-mutated-ovarian-cancer-patients","name":"brca or hrr mutated ovarian cancer patients"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02476968","title":"To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":181,"lead_sponsor_name":"AstraZeneca","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}